Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 13,199 $ 112,809
Marketable securities- Related Party 82,376 107,912
Total Current Assets 95,575 220,721
Total Assets 95,575 220,721
Current Liabilities    
Accounts payable and accrued expenses 1,718,922 1,381,849
Convertible note payable, net of debt discount of $0 and $0 as of December 31, 2024 and 2023 173,192 173,192
Convertible note payable, net of debt discount 525,000 516,496
Total Current Liabilities 5,166,681 4,763,604
Total Liabilities 5,166,681 4,763,604
Commitments and Contingencies (Note 7)
Stockholders’ Deficit    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of December 31, 2024 and 2023
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of December 31, 2024 and 2023, respectively 2,167 2,167
Additional paid-in capital 810,048 810,048
Accumulated deficit (5,883,321) (5,355,098)
Total Stockholders’ Deficit (5,071,106) (4,542,883)
Total Liabilities and Stockholders’ Deficit 95,575 220,721
Related Party [Member]    
Current Liabilities    
Accounts payable - related party 911,659 911,659
Short -term advances - related party 1,731,058 1,673,558
Notes payable - related party - net of debt discount of $0 and $0 as of December 31, 2024 and 2023 $ 106,850 $ 106,850